Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial ...

The probability of worsening frailty increases over time, but targeted strategies might delay or reverse this progression, ...

In a study published in European Heart Journal on December 26, a research team from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of ...

The 50-year-old Romanian national suffered a sudden cardiac arrest while playing pickleball in Vietnam's capital city Hanoi ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial programme ...

Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics ...

A FRESH study has found that those who smoke e-cigarettes or vapes could be at a higher risk of heart attacks, particularly if they used to smoke cigarettes. Researchers urged users to recognise ...

Brainomix AI core lab uses regulatory cleared stroke technology, alongside its foundation-model-powered imaging pipeline for clinical trials, to provide robust baseline phenotyping and efficacy ...

A systematic review of 17 randomized trials found that among high cardiovascular risk individuals, reducing saturated fat was linked to lower all-cause mortality and possible reductions in ...

Dick Clark's New Year's Rockin' Eve host Dick Clark was married to Kari Wigton for over three decades. Find out all about ...

Patients on tirzepatide also experienced more metabolic benefits, such as greater reductions in weight and HbA1c, compared with dulaglutide.

On December 17, Lale Akoner, Global Market Analyst at eToro, appeared on CNBC to suggest that she is observing capital moving ...